Applications of 3-Aminophenylboronic Acid Monohydrate in Industrial Manufacturing

As a direct manufacturer with years of experience serving advanced chemical sectors, we supply 3-Aminophenylboronic Acid Monohydrate to key downstream industries. Our material is integrated into critical syntheses for pharmaceuticals, functional materials, diagnostic reagents, and agrochemical intermediates. Below we present detailed industrial applications, compliance references, formulation practices, manufacturing integration points, and typical downstream finished products.

1. Pharmaceutical API Intermediate Synthesis

3-Aminophenylboronic Acid Monohydrate acts as a building block for active pharmaceutical ingredient (API) intermediates, especially for kinase inhibitors and proteasome inhibitor families. Manufacturers rely on its boron functionality and amino group compatibility in Suzuki-Miyaura cross-coupling reactions to construct complex biaryl and heteroaryl systems. The compound supports efficient production of regulated API intermediates by providing high selectivity and minimal by-product formation in multi-step syntheses.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
• 21 CFR Part 211 Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
• European Pharmacopoeia (Ph. Eur.) cross-references for process quality
• USP General Chapter <797> for compounding sterile preparations

Typical usage ratio

• 0.85–1.2 molar equivalents in Suzuki reactions, tuned according to aryl halide and catalyst system
• Adjusted batch-wise after in-process HPLC monitoring

Downstream process integration

• Introduced directly in the cross-coupling stage, following aryl halide activation
• Pre-purification step managed via aqueous workup and solvent exchange for API intermediates
• Final purification by column chromatography or preparative HPLC

Final product types

• Kinase inhibitor intermediates (e.g., for oncology drugs)
• Proteasome inhibitor building blocks (e.g., bortezomib synthesis)
• Zinc finger modulator scaffolds
• Custom medicinal chemistry intermediates

2. Electrochemical Sensor and Diagnostic Reagent Manufacturing

Diagnostic companies use 3-Aminophenylboronic Acid Monohydrate in fabrication of electrode surface modifiers for glucose biosensor devices, carbohydrate-detecting strips, and in affinity-tagged fluorescent probes. The amino-boronic acid functional group forms reversible covalent bonds with diols, enabling targeted immobilization of saccharides or glycoproteins onto gold or carbon surfaces. Its purity and aqueous solubility make it suitable for GMP medical device reagent kits.

Industry compliance standards

• ISO 13485:2016 Medical Devices – Quality Management Systems
• EN ISO 14971 Medical Device Risk Management Standard
• 21 CFR Part 820 Quality System Regulation (US FDA)
• REACH Regulation (EC) No. 1907/2006 for chemical safety

Typical usage ratio

• Surface concentrations: 1–10 mM for electrode modification
• Batch formulations: 0.05–0.5% w/v in coating solutions, adjusted based on probe or strip hydrophilicity

Downstream process integration

• Applied in the electrode/device surface coating step post-cleaning and pre-sensor assembly
• Coupled with EDC/NHS activation for immobilization on sensor substrates
• Stabilized by lyophilization or packaging under inert conditions

Final product types

• Blood glucose test strips
• Continuous glucose monitoring sensors
• Diagnostic glycoprotein microarray chips
• Affinity-based fluorescence assays

3. Polymer Additive for Boron-Containing Functional Materials

Manufacturers of advanced polymers incorporate 3-Aminophenylboronic Acid Monohydrate to impart boronic acid functionality, enabling subsequent cross-linking or molecular recognition capabilities. Polymeric materials containing this component demonstrate enhanced affinity for cis-diol biomolecules and utility in stimuli-responsive hydrogels, drug delivery vehicles, and selective separation membranes. Its direct addition during copolymerization or post-polymer functionalization assures precise control over polymer matrix properties for specialty applications.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems
• ISO 10993-1 Biological Evaluation of Medical Devices for biomaterial applications
• REACH (EC 1907/2006) compliance for polymer additives
• FDA 21 CFR 177.1520 for polymer contact with food (if applicable)

Typical usage ratio

• 0.5–5 mol% as a comonomer relative to primary monomer, depending on targeted functionalization
• 1–10% by weight for post-polymer modification processes

Downstream process integration

• Added during monomer charge in emulsion or solution copolymerization reactors
• Post-polymer grafting by amidation or Schiff base formation under mild conditions
• Purification through dialysis and precipitation

Final product types

• Boron-functionalized hydrogels
• Affinity chromatography resins
• Membranes for glycoprotein isolation
• Smart drug carrier nanoparticles

4. Agrochemical Intermediate and Plant Growth Regulator Synthesis

Agrochemical producers utilize 3-Aminophenylboronic Acid Monohydrate for the synthesis of specific boron-containing pesticide intermediates and plant growth regulators. The amino and boronic functional groups enable targeted derivatization and efficient coupling with halogenated aromatics and carboxylic acids, producing key molecular fragments for herbicides and selective fungicides. Manufacturers choose this intermediate for its high reactivity and reliability in large-scale automated reactor systems.

Industry compliance standards

• FAO/WHO Specifications for Plant Protection Products
• ISO 9001:2015 Quality Management Systems for agrochemical production
• European Union Regulation (EC) No 1107/2009 for placing plant protection products on the market
• REACH (EC) 1907/2006 for substance registration and safe use

Typical usage ratio

• 1–1.1 molar equivalents relative to crop-protection halide, based on stoichiometric coupling efficiency
• Adjusted per production scale using in-process analytical monitoring

Downstream process integration

• Fed into coupling reaction zones after catalyst pre-conditioning
• Intermediate purification with phase separation, followed by distillation or crystallization
• Crude product conversion to formulated technical concentrates or further downstream intermediates

Final product types

• Aromatic boronic acid-based pesticide intermediates
• Plant growth modulator precursors
• Boron-complexed agricultural additives
• Herbicide or fungicide synthetic intermediates